In a double-blind, randomized and placebo-controlled trial, adjuvant memantine improved symptoms in inpatients suffering from refractory obsessive-compulsive disorders (OCD)

被引：0
|
作者：
Mohammad Haghighi
Leila Jahangard
Hamid Mohammad-Beigi
Hafez Bajoghli
Hassan Hafezian
Alireza Rahimi
Hamid Afshar
Edith Holsboer-Trachsler
Serge Brand
机构：
[1] Hamadan University of Medical Sciences,Research Center for Behavioral Disorders and Substances Abuse
[2] Isfahan University of Medical Sciences,Isfahan Psychosomatic Research Center
[3] Tehran University of Medical Sciences,Psychiatry and Psychology Research Center (PPRC), Roozbeh Hospital
[4] Psychiatric Hospital of the University of Basel,Center for Affective, Stress and Sleep Disorders (ZASS)
来源：
Psychopharmacology | 2013年 / 228卷
关键词：
Obsessive–compulsive disorder; Memantine; SSRIs; Double-blind trial; Placebo; Y-BOCS;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：633 / 640
页数：7
相关论文
共 50 条
  • [21] Aripiprazole as an adjuvant treatment for obsessive and compulsive symptoms in manic phase of bipolar disorder: A randomized, double-blind, placebo-controlled clinical trial
    Sahraian, Ali
    Ehsaei, Zahra
    Mowla, Arash
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2018, 84 : 267 - 271
  • [22] Granisetron Adjunct to Fluvoxamine for Moderate to Severe Obsessive-Compulsive Disorder A Randomized, Double-Blind, Placebo-Controlled Trial
    Askari, Neda
    Moin, Mandieh
    Sanati, Mohammad
    Tajdini, Masih
    Hosseini, Seyed-Mohammad-Reza
    Modabbernia, Amirhossein
    Najand, Babak
    Salimi, Samrand
    Tabrizi, Mina
    Ashrafi, Mandana
    Hajiaghaee, Reza
    Akhondzadehl, Shahin
    CNS DRUGS, 2012, 26 (10) : 883 - 892
  • [23] Granisetron Adjunct to Fluvoxamine for Moderate to Severe Obsessive-Compulsive DisorderA Randomized, Double-Blind, Placebo-Controlled Trial
    Neda Askari
    Mahdieh Moin
    Mohammad Sanati
    Masih Tajdini
    Seyed-Mohammad-Reza Hosseini
    Amirhossein Modabbernia
    Babak Najand
    Samrand Salimi
    Mina Tabrizi
    Mandana Ashrafi
    Reza Hajiaghaee
    Shahin Akhondzadeh
    CNS Drugs, 2012, 26 : 883 - 892
  • [24] Paroxetine treatment in children and adolescents with obsessive-compulsive disorder: A randomized, multicenter, double-blind, placebo-controlled trial
    Geller, DA
    Wagner, KD
    Emslie, G
    Murphy, T
    Carpenter, DJ
    Wetherhold, E
    Perera, P
    Machin, A
    Gardiner, C
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2004, 43 (11): : 1387 - 1396
  • [25] Pregabalin augmentation for resistant obsessive-compulsive disorder: a double-blind placebo-controlled clinical trial
    Mowla, Arash
    Ghaedsharaf, Mehrnoosh
    CNS SPECTRUMS, 2020, 25 (04) : 552 - 556
  • [26] Combination of clomipramine and nortriptyline in the treatment of obsessive-compulsive disorder: a double-blind, placebo-controlled trial
    Noorbala, AA
    Hosseini, SH
    Mohammadi, MR
    Akhondzadeh, S
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 1998, 23 (02) : 155 - 159
  • [27] Reboxetine Combination Therapy With Fluoxetine in Moderate to Severe Obsessive-Compulsive Disorder: A Placebo-Controlled, Double-Blind, Randomized Trial
    Tilaki, Erfaneh Hajian
    Hasanzadeh, Alireza
    Shalbafan, Mohammadreza
    Moghaddam, Hossein Sanjari
    Shamabadi, Ahmad
    Boroon, Mahsa
    Akhondzadeh, Shahin
    CLINICAL NEUROPHARMACOLOGY, 2023, 46 (05) : 175 - 180
  • [28] Naproxen adjunct to fluoxetine for moderate-to-severe obsessive-compulsive disorder: A randomized, double-blind, placebo-controlled trial
    Shamabadi, Ahmad
    Motavalian, Zahra
    Farahmand, Yalda
    Farahmand, Kimia
    Arabzadeh Bahri, Razman
    Askari, Sanaz
    Ansari, Sahar
    Fallahzadeh, Mohammadali
    Shalbafan, Mohammdreza
    Akhondzadeh, Shahin
    PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2024, 78 (12) : 810 - 817
  • [29] Is quetiapine effective for obsessive and compulsive symptoms in patients with bipolar disorder? A randomized, double-blind, placebo-controlled clinical trial
    Sahraian, Ali
    Ghahremanpouri, Bahareh
    Mowla, Arash
    CNS SPECTRUMS, 2022, 27 (05) : 634 - 638
  • [30] Memantine as an Adjuvant Treatment for Obsessive Compulsive Symptoms in Manic Phase of Bipolar Disorder. A Randomized, Double-Blind, Placebo-Controlled Clinical Trial (vol 37, pg 246, 2017)
    Sahraian, Ali
    Jahromi, Leila Razeghian
    Ghanizadeh, Ahmad
    Mowla, Arash
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2017, 37 (04) : 434 - 434
12345